<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="bnf-extra" /><meta name="keywords" content="" /><title>What’s new in BNF 63?: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="450035.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="450035.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=450035.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="204285.htm" title="Previous: Yellow Card Scheme">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="450016.htm" title="Next: Calculators">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1 id="_450035">What’s new in <em>BNF</em> 63?</h1><?highlighter on?><div id="pC" class="jN">
		
				<p>Welcome to <em>BNF</em> 63.We have highlighted below some of the key changes you will find in this new edition.</p>
				
				<h2>Updated prescribing information</h2>

				<h3>Bowel cleansing preparations</h3>
				<p>Guidance on the safe use of bowel cleansing preparations has been updated in BNF 63 (<a href="2258.htm">section 1.6.5</a>). Before initiating this treatment, healthcare professionals are reminded to measure the renal function of patients at risk of fluid and electrolyte disturbances, and to correct hypovolaemia. Because absorption may be impaired, other oral drugs should not be taken one hour before or after administration of bowel cleansing preparations. Consideration should also be given to:</p>
				<ul>
					<li>withholding diuretics on the day that a bowel cleansing preparation is given;</li>
					<li>withholding ACE inhibitor, angiotensin-II receptor antagonist, or NSAID treatment on the day that a bowel cleansing preparation is given and for up to 72 hours after the procedure.</li>
				</ul>


				<h3>Stable angina</h3>
				<p>Guidance on the management of stable angina has been updated in <a href="204277.htm">section 2.10.1</a> to reflect the recommendations of NICE Clinical Guideline 126: <i>Management of stable angina</i> (July 2011). Advice is given on recommended treatment options and on long-term prevention of cardiovascular events</p>
				
				<h3>Hypertension</h3>
				<p>Guidance for the management of hypertension has been updated in <a href="2534.htm">section 2.5</a> to reflect the recommendations of NICE Clinical Guideline 127: <i>Hypertension—Clinical management of primary hypertension in adults</i> (August 2011). Advice is given on thresholds, targets, and drug treatment of hypertension.</p>
				
				<h3>Oral anticoagulants</h3>
				<p>For BNF 63, guidance on the use and monitoring of warfarin has been updated in <a href="201052.htm">section 2.8.2</a> to reflect the recommendations of the British Committee for Standards in Haematology: Guidelines on Oral Anticoagulation with Warfarin—fourth edition. <i>Br J Haematol</i> 2011; <b>154</b>: 311–24. Advice is given on INR targets, duration of treatment, management of peri-operative anticoagulation, and management of patients receiving combined anticoagulant and antiplatelet therapy.</p>
				
				<h3>Antiepileptic hypersensitivity syndrome</h3>
				<p>Guidance on antiepileptic hypersensitivity syndrome has been added to <a href="3575.htm">section 4.8.1</a>. Antiepileptic hypersensitivity syndrome is a rare but potentially fatal syndrome associated with some antiepileptic drugs. The symptoms usually start between week 1 and week 8 of exposure; fever, rash, and lymphadenopathy are most commonly seen. Other systemic signs include liver dysfunction, haematological, renal, and pulmonary abnormalities, vasculitis, and multi-organ failure. If signs or symptoms of hypersensitivity syndrome occur, the drug should be withdrawn immediately, the patient must not be re-exposed, and expert advice should be sought.</p>
				
				<h3>Changing from a progestogen-only oral contraceptive</h3>
				<p>For BNF 63, the advice on changing from an oral progestogen-only contraceptive to a combined oral contraceptive has been updated in <a href="4553.htm">section 7.3.1</a>. If the oral progestogen-only contraceptive has been used correctly, or if pregnancy can reasonably be excluded, a woman should start the combined oral contraceptive immediately but additional precautions (barrier methods) are necessary for the first 7 days.</p>
				
				<h3>Antithyroid drugs in pregnancy</h3>
				<p>For BNF 63, the advice on the use of antithyroid drugs in pregnancy has been updated in <a href="4242.htm">section 6.2.2</a>. Propylthiouracil remains the drug of choice during the first trimester of pregnancy because of the rare risk of congenital defects with carbimazole. In the second trimester, a switch to carbimazole should be considered because of the potential risk of hepatotoxicity with propylthiouracil.</p>
				
				<h3>NSAIDs and gastro-intestinal events</h3>
				<p>The advice in <a href="5183.htm">section 10.1.1</a> regarding NSAIDs and gastro-intestinal events has been revised for BNF 63 and includes updated information on the relative safety of individual non-selective NSAIDs in terms of risk of serious upper gastro-intestinal side-effects.</p>
				
				<h2>No price update for BNF 63</h2>
				<p>The BNF is currently changing its process for updating prices of non-proprietary and branded preparations in an effort to improve the accuracy of the data presented. In past editions, pricing data has been obtained from the NHSBS (formerly the PPD) via the DM+D service; this will remain the source of our data, however the work involved in automating this process is ongoing. As a result, we are unable to update the prices in BNF 63, and prices will therefore remain unchanged from those in BNF 62.</p>
				
				<h2>Learning with the BNF</h2>
				<h3>BNF e-learning modules for pharmacists</h3>
				<p>BNF Update is an e-learning programme developed in collaboration with the Centre for Pharmacy Postgraduate Education (CPPE). Using a series of clinical case studies, the programme enables pharmacists to identify and assess how significant changes in the latest BNF affect their clinical practice. There are two e-learning programmes: one for pharmacists working in the community and other primary care settings, and another aimed at hospital pharmacists. New modules will be released every 6 months to complement the publication of each new edition of the BNF. Recognised as an essential component of every pharmacist’s continuing professional development, BNF Update can be accessed free of charge by pharmacists and pre-registration pharmacists in England at <a href="http://www.cppe.ac.uk">http://www.cppe.ac.uk</a>.</p>
				
				<h2>BNF and BNFC e-newsletter</h2>
				<p>The BNF &amp; BNFC free e-newsletter is issued several times a year. To register for regular updates, case studies,	and tips on using these publications effectively, please sign up at <a href="http://www.bnf.org/newsletter">www.bnf.org/newsletter</a>. To visit the e-newsletter archive, go to <a href="http://www.bnf.org/bnf/org_450066.htm">http://www.bnf.org/bnf/org_450066.htm</a>.</p>
				
				<h2>Other significant changes</h2>
				<p>Numerous changes are made for each edition of the BNF. The most significant changes that have been made for <em>BNF</em> 63 can be reviewed by following the links below:</p>
				
				<ul>
					<li><a href="63576.htm">Changes to prescribing notes</a> for <em>BNF</em> 63</li>
					<li><a href="63577.htm">Dose changes</a></li>
					<li><a href="63580.htm">Classification changes</a></li>
					<li><a href="204273.htm">New names</a></li>
					<!--<li><a pub="bnf" href="128297.htm">Late additions</a> (new preparations)</li>-->
					<li><a href="66795.htm">Preparations discontinued</a> since previous edition</li>
					<li><a href="100012.htm">Preparations added</a> to <em>BNF</em> 63</li>
				</ul>
			
	</div><?highlighter on?><?highlighter off?><div id="pE">◄ <a accesskey="[" href="204285.htm">Previous: Yellow Card Scheme</a> | <a class="top" href="450035.htm#">Top</a> | <a accesskey="]" href="450016.htm">Next: Calculators</a> ►</div></div></div><script type="text/javascript" src="scripts/extra.js"></script><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>